Frazier Healthcare VI, L.P.

Frazier Healthcare VI, L.P. discloses dealings in 2 companies, chiefly Molecular Templates, Inc. and Collegium Pharmaceutical, Inc. We count 17 filings; the first trade dates from 16 March 2011 and the latest from 12 May 2015.

The open-market side counts 4 purchases for €5.8M alongside 9 sales for €63.2M. Taken together, the sales exceed the purchases by €57.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2015 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €1.4M.

The latest filing, published on 14 May 2015, reports an open-market purchase of €1.6M in Collegium Pharmaceutical, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.